Bupaq Multidose
General data
Product class:
Medicinal product with marketing authorization
Medicinal product class:
Veterinary medicine
Name of medicinal product:
Bupaq Multidose
Active substances:
Buprenorphine
Estonian
,
English
,
Latin
ATC code:
QN02AE01
Dosage form:
solution for injection
Strength:
0,3mg 1ml
Legal status for supply*:
Prescription for narcotic drugs
Summary of product characteristics (SPC):
(last updated 27 February 2023)
Package information leaflet (PIL):
EST
(last updated 22 June 2023)
Labelling:
(last updated 27 February 2023)
Indication:
DOG Post-operative analgesia. Potentiation of the sedative effects of centrally-acting agents. CAT Post-operative analgesia.
Safety features:
No
Marketing authorization
Marketing authorization holder:
Vetviva Richter GmbH
Marketing authorization number:
1812
Marketing authorization issued on:
20 December 2013
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Mutual recognition
Assessment report:
(last updated 20 December 2013)
Packages approved by this marketing authorization
Package code
Name of medicinal product
Dosage form
Package
Legal status
Reimbursements
Reference price
Last imported
PƤritolumaa
Additional information
1622540
Bupaq Multidose
solution for injection
0,3mg 1ml 10ml 1TK
N
21/11/2023
1622551
Bupaq Multidose
solution for injection
0,3mg 1ml 10ml 5TK
N
1622562
Bupaq Multidose
solution for injection
0,3mg 1ml 10ml 10TK
N
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription